Drug Profile
AT 3510
Alternative Names: AT 708SLatest Information Update: 10 Nov 2006
Price :
$50
*
At a glance
- Originator Kyorin Pharmaceutical
- Class Antineoplastics
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer